Evidence map›Paper›PMID 34816784›Full record

ArticleGut microbes

Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties.

Asif Halimi, Giorgio Gabarrini, Michał Jacek Sobkowiak, Zeeshan Ateeb, Haleh Davanian, Rogier Aäron Gaiser, Urban Arnelo, Roberto Valente, Alicia Y W Wong, Carlos Fernández Moro and 3 more

Open access · goldAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
2.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Asif HalimiDivision of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-0343-8978
Giorgio GabarriniDepartment of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
Michał Jacek SobkowiakDepartment of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
Zeeshan AteebDivision of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Haleh DavanianDepartment of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
Rogier Aäron GaiserDepartment of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.
Urban ArneloDivision of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Roberto ValenteDivision of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Alicia Y W WongDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Carlos Fernández MoroDivision of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Marco Del ChiaroDepartment of Surgery, University of Colorado Denver - Anschutz Medical Campus, Aurora, CO, USA.
Volkan ÖzenciDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Margaret Sällberg ChenDepartment of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-3793-4064
Karolinska Institutet · SEKarolinska University Hospital · SEUniversity of Colorado Anschutz Medical Campus · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging research suggests gut microbiome may play a role in pancreatic cancer initiation and progression, but cultivation of the cancer microbiome remains challenging. This pilot study aims to investigate the possibility to cultivate pancreatic microbiome from pancreatic cystic lesions associated with invasive cancer. Intra-operatively acquired pancreatic cyst fluid samples showed culture-positivity mainly in the intraductal papillary mucinous neoplasm (IPMN) group of lesions. MALDI-TOF MS profiling analysis shows Gammaproteobacteria and Bacilli dominate among individual bacteria isolates. Among cultivated bacteria, Gammaproteobacteria, particularly

Indexed as

DNA DamageAgedAged, 80 and overAnti-Bacterial AgentsBacteriaCell DeathCell LineFemaleHumansMaleMicrobial ViabilityMicrobiotaPancreatic Intraductal NeoplasmsPilot ProjectsAnti-Bacterial AgentsIPMNmicrobiotaPancreatic cancerpancreatic cystic neoplasm

Identifiers

PMID34816784
PMCPMC8632270
OpenAlexW3215395566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.